Cancer Research Funding Awarded to Providence College

NEC member Providence College was recently awarded a National Institute of Health (NIH) grant for cancer research.

With the provided funding of $257,049, the Rev. and Dr. Nicanor Austriaco along with Providence College students will be studying the “Bax inhibitor-1” gene that has been linked to lymphoma, leukemia, and breast and prostrate cancer. Their research project, titled “Genetic Dissection of Yeast Bax Inhibitor Function in UPR and Calcium Signaling,” aims to help develop better treatment for cancer patients whose cancers are linked to the “Bax inhibitor-1” gene. Funding for this joint faculty-student project gives student the opportunity to work together to fight cancer. The grant provides three years of funding, beginning in May 2014

This is the second NIH Academic Research Enhancement Award (AREA) grant awarded to Fr. Austriaco in four years. The award funds small scale research in biomedical and behavioral sciences that supports collaboration between faculty and students.  The New England Council congratulates Providence College on this award and for ongoing efforts to fight cancer.


Read more in the Providence Business Journal or Providence College’s press release.



Recently from the Blog

Bridgewater State Announces Scholarship honoring Marathon Bombing Victim

10/25/2021 | Read Post

McDonald’s Sets Net Zero Emissions Goal  

10/25/2021 | Read Post

In the News

NEC to Honor Historic All-Female Lineup of 2021 New Englanders of the Year

08/2/2021 | Read Press Release

NEC Board Elects Three New Directors

04/27/2021 | Read Press Release